-
Soligenix Announces Reverse-Split in Preparation for Proposed Up-Listing of its Common Stock to the NASDAQ Capital Market
Post on 10/7/16
-
3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity
Post on 10/7/16
-
Domain Associates-backed Obalon Therapeutics Rolls Out IPO
Post on 10/6/16
-
Trice Medical Receives FDA 510(K) Clearance for mi-eye 2
Post on 10/6/16
-
Better Buy: Anavex Life Sciences Corp. vs. Ionis Pharmaceuticals, Inc.
Post on 10/6/16
-
This Looks to Be Johnson & Johnson's Next Blockbuster Drug
Post on 10/6/16
-
Idera Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post on 10/6/16
-
Immunomedics Announces $30 Million Financing
Post on 10/5/16
-
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Post on 10/5/16
-
What Clinton and Trump Would Do to Medicare
Post on 10/5/16
-
Tabula Rasa HealthCare Closes IPO
Post on 10/5/16
-
Daiichi Sankyo Announces New Strategic Immuno-Oncology Research Collaboration with AgonOx
Post on 10/4/16
-
Living with Hepatitis B: Hepatitis B Foundation Launches Patient Storytelling Campaign
Post on 10/4/16
-
NJ Spine and Wellness Celebrates with Grand Opening Event at New Freehold Location
Post on 10/4/16
-
5 Reasons Why I Continue To Buy Johnson & Johnson
Post on 10/4/16
-
Instant Analysis: Celgene Pays $600 Million for Swiss Biotech
Post on 10/4/16
-
Children's Hospital of Philadelphia Opens Pediatric Urgent Care Center in Glen Mills, PA
Post on 10/3/16
-
Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson
Post on 10/3/16
-
Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It
Post on 10/3/16
-
Is Celgene the Smartest Buyer in Biotech?
Post on 10/3/16
-
Hillary Clinton vs. Donald Trump on Obamacare
Post on 10/3/16
-
ContraVir to Receive $1.8 Million Through New Jersey Technology Business Tax Certificate Transfer Program
Post on 9/29/16
-
This Nurse is Launching a Subscription Service for Couples Trying to Get Pregnant
Post on 9/29/16
-
FamilyWize Reaches “10 Million People Helped and $1 Billion in Prescription Savings” Since 2005
Post on 9/29/16
-
Why Johnson & Johnson's New Wearable for Diabetics Should Be a Home Run
Post on 9/29/16
Philadelphia
